Degenerative cervical myelopathy (DCM) is a progressive neurodegenerative disorder. DCM is common (estimated prevalence, 2% of adults) and significantly impacts quality of life. The AO Spine RECODE-DCM (Research Objectives and Common Data Elements in DCM) project has recently established the top research priorities for DCM. This article examines the extent to which existing research activity aligns with the established research priorities.
A systematic review of MEDLINE and Embase for “Cervical” AND “Myelopathy” was conducted following PRISMA guidelines. Full-text papers in English, exclusively studying DCM, published between January 1, 1995 and August 08, 2020 were considered eligible. Extracted data for each study included authors, journal, year of publication, location, sample size and study design. Each study was then analysed for alignment to the established research priorities.
In total, 2261 papers with a total of 1,323,979 patients were included. Japan published more papers (625) than any other country. Moreover, 2005 (89%) of 2261 papers were aligned to at least one research priority. The alignment of papers to the different research priorities was unequal, with 1060 papers on the most researched priority alone (#15, predictors of outcome after treatment), but only 64 total papers on the least-researched 10 priorities. The comparative growth of research in the different priorities was also unequal, with some priorities growing and others plateauing over the past 5 years.
Research activity in DCM continues to grow, and the focus of this research remains on surgery. The established research priorities therefore represent a new direction for the field.
Degenerative cervical myelopathy (DCM) is a progressive neurological condition defined by symptomatic spinal cord compression caused by arthritic narrowing of the spinal canal . It is common, estimated to affect as many as 2% of adults , and has a significant impact on health-related quality of life .
The AO Spine RECODE-DCM (Research Objectives and Common Data Elements in DCM) project is an international collaboration, supported by the AO Spine Foundation and Myelopathy.org, which aims to accelerate knowledge discovery in DCM, through a number of consensus initiatives, including a James Lind Alliance priority setting process to establish the top research priorities for DCM (Table 1). Research priorities were selected through consensus from a longlist of 74 unanswered research questions. The longlist was formed by first consolidating 3404 research suggestions, from an international and multi-disciplinary community into unique research questions, and second checking current evidence to ensure these are unanswered (aospine.org/recode).
In order for this prioritisation process to have its desired effect, the priorities must be adopted by the research community. Therefore, a next stage of the project involves promoting their uptake. This process, known often as knowledge translation (KT), is critical in bridging the gap between the acquisition of knowledge (in this case, the research priorities) and the implementation of this knowledge into practice (ensuring that future research is aligned with the priorities).
The first step in the KT process is to establish a baseline to define the gap that needs to be bridged and a reference point for which KT interventions can be measured against. This article therefore aims to establish the extent to which existing and emerging research activity aligns with the newly identified research priorities.
Primary clinical trials contained within the Myelopathy.org Literature Database on DCM were evaluated for alignment with the research priorities included in the final face-to-face consensus meeting.
Myelopathy.org literature database
Systematic review and meta-analysis, otherwise known as research synthesis, are important tools to quantitatively summarise current knowledge about a topic. Their findings are fundamentally underpinned on the studies that they identify. Within the field of DCM, there is inconsistent disease terminology, with an absence of index terms or codes , which makes literature searching extremely inefficient. For this reason, and to support work by the Myelopathy.org charity, a hand indexed database of primary clinical articles has been maintained.
The dataset was built using a search of Embase and MEDLINE for [“Cervical”] AND [“Myelopathy”]. It includes primary clinical human trials, in which DCM is the primary condition being addressed, with the full text available in English. Animal studies, case reports, letters, editorials, reviews, technical notes, commentaries, proposals and corrections were excluded.
The database was initially built on previous systematic reviews [2, 3] and initially contained all papers published up to December 31, 2015 . The last update was performed on August 08, 2020. This updated database forms the basis of this study.
Each paper was assessed (by authors BG, HB, FB, RD, MK, CIPS, JQT) for alignment to the established research priorities. Each paper was allocated to one or more priorities, or deemed to be not aligned to any priority.
The following information was extracted for each paper: title, abstract, author names, country of corresponding author, year of publication, research theme (as per ), patient characteristics (number of patients, surgical vs. non-surgical treatment) and study design (prospective or retrospective, cohort or case-control, level of evidence).
Statistical analysis was used to detect differences in research activity between research priorities and over time. SPSS Statistics (IBM Corporation, Armonk, NY) was used for all calculations. Shapiro-Wilk tests were used to analyse normality of data, and parametric or non-parametric tests were used accordingly. Significance was set at p < .05. We report mean ± standard deviation unless otherwise specified.
Summary of global dataset
In total, 2261 papers, with a total of 1,323,979 patients (median, 63 patients in the 2230 articles that reported an N), were included. Japan has published more papers (625, 27.6% of total) than any other country, whilst the USA studied the greatest number of patients (4,549,916). The aggregate global distribution of research activity is shown in Fig. 1 and per priority in Supplementary Data 3. Moreover, 727 (32.2%) papers reported a prospective design, whilst 806 (35.6%) studies reported a retrospective design. Furthermore, 728 (32.2%) papers had an unreported/unclear design.
Aggregate data per priority
Summary data for each priority are shown in Table 2. A substantial proportion (256/2261, 11.3%) of papers were not aligned to any priority. Those papers assigned to a priority were unevenly distributed. For instance, 1060/2261 (47%) of papers were assigned to priority #15 (predictors of outcome after treatment), whilst there were nine priorities that had fewer than 10 papers each (Table 3).
Median sample sizes for each priority are shown in Fig. 2. There was a statistically significant difference in the distribution of sample sizes between priorities (p = <0.001, independent-samples Kruskal-Wallis test).
The research activity in DCM over time is shown in Fig. 3 and Supplementary Data 2. Growth of research activity in the different priorities is significantly different (p = <0.001, Pearson Chi-squared test). For example, one priority (#21, management of mild DCM) had no papers published in the past 5 years, whilst another priority (#13, symptom management) had 33% of all its papers published in the past 5 years. Within the last 5 years, three priorities have shown consistent growth – #4 (assessment and monitoring), #9 (imaging techniques) and #15 (predictors of outcome after treatment).
Research activity in DCM continues to grow, and whilst a number of priorities appear to be an increasing focus for researchers, the majority of published research is not aligned with the newly established research priorities with many priorities showing little aligned activity.
Research activity in DCM continues to grow
This study was based on 2261 papers that form the entire literature in DCM over the past 25 years – a relatively small research output compared to other diseases of similar prevalence. Despite this, research activity has continued to grow since our last evaluation , with 968 new papers since January 1, 2016. In line with our previous findings, the focus of DCM research remains on surgery. In particular, the determinants of outcome after surgery (aligned with Priority #15) have been a particular focus. These determinants may include the choice and timing of the surgical procedure [6, 11, 12].
Research activity in DCM does not align with newly established research priorities
With the exception of Priority #15 (determinants of post-treatment outcome), the established research priorities have been under-represented. We found more papers not aligned to any research priority (‘/’, 256 papers) than aligned to any individual priority other than #15 and #4 (Table 3). This is emphasised when examining the most important priorities – the #1 priority (raising awareness) has only eight papers aligned to it, and the top ten priorities have only 780 papers between them, less than 35% of the 2261 included papers. Furthermore, there is inequality in research activity amongst the research priorities – both in cumulative counts (Tables 2 and 3) and in recent growth (Fig. 3).
It should be acknowledged that these priorities are newly established and reflect on-going clinical uncertainties. The literature included in this review spans 25 years, during which time the research priorities may have been different. For example, it is notable that during this period the evidence base for surgical management has increased significantly (as reflected within the AO Spine Guidelines ), which is in line with substantial research activity . These findings therefore do not dismiss previous research but aim to highlight the present directions and knowledge translation gap. However, this example does highlight the logical correlation between a research focus and clinical progress, substantiating within DCM the premise and potential for research priority setting .
Role of this paper
This paper therefore serves several roles. Firstly, it acts as a collection of research papers, comprising the entire current DCM literature, to serve as a reference for current research. Secondly, it indicates the magnitude of change required to address the research priorities, indicating which priorities in particular are under-researched. Both the established order of importance and the existing number of papers aligned to each priority may be used to guide researchers in choosing a topic for research. Thirdly, it acts as a baseline, against which the success of the AO Spine RECODE-DCM project, and in particular its KT strategy, may be measured against in the future.
As we have published previously , owing to the difficulties in indexing DCM literature, the results presented here are based upon an extensive hand search of the literature (title and abstract only). Whilst this may introduce an element of subjectivity – the reviewers must decide which papers meet the pre-established criteria and which do not and this is not always clear – this was the preferred approach to ensure a more comprehensive representation of the field. Given this breadth and the number of studies captured, we are confident that the overall findings are a true reflection of the DCM research field, although we note the need for reproducibility of methods in future research of this type. Establishing a clear set of disease codes to combat this problem is one of the aims of the AO Spine RECODE-DCM project and will help to address this for the future.
Previous and emerging DCM research does not align with the newly established research priorities. This poses a challenge for the uptake and implementation of the research priorities. However, the strong correlation between surgical research activity over the last 25 years and the advances for its evidence indicate that if this can be achieved it will pay dividends.
Davies BM, Khan DZ, Mowforth OD, McNair AGK, Gronlund T, Kolias AG, Tetreault L, Starkey ML, Sadler I, Sarewitz E, Houlton D, Carter J, Kalsi-Ryan S, Aarabi B, Kwon BK, Kurpad SN, Harrop J, Wilson JR, Grossman R, Curt A, Fehlings MG, Kotter MRN (2019) RE-CODE DCM (REsearch Objectives and Common Data Elements for Degenerative Cervical Myelopathy): a consensus process to improve research efficiency in DCM, through establishment of a standardized dataset for clinical research and the definition of the research priorities. Global Spine J 9:65S–76S. https://doi.org/10.1177/2192568219832855
Davies BM, McHugh M, Elgheriani A, Kolias AG, Tetreault L, Hutchinson PJ, Fehlings MG, Kotter MR (2017) The reporting of study and population characteristics in degenerative cervical myelopathy: a systematic review. PLoS One 12:e0172564. https://doi.org/10.1371/journal.pone.0172564
Davies BM, McHugh M, Elgheriani A, Kolias AG, Tetreault LA, Hutchinson PJ, Fehlings MG, Kotter MR (2016) Reported outcome measures in degenerative cervical myelopathy: a systematic review. PLoS One 11:e0157263. https://doi.org/10.1371/journal.pone.0157263
Davies BM, Mowforth OD, Smith EK, Kotter MR (2018) Degenerative cervical myelopathy. BMJ 360:k186. https://doi.org/10.1136/bmj.k186
Fehlings MG, Tetreault LA, Riew KD, Middleton JW, Aarabi B, Arnold PM, Brodke DS, Burns AS, Carette S, Chen R, Chiba K, Dettori JR, Furlan JC, Harrop JS, Holly LT, Kalsi-Ryan S, Kotter M, Kwon BK, Martin AR, Milligan J, Nakashima H, Nagoshi N, Rhee J, Singh A, Skelly AC, Sodhi S, Wilson JR, Yee A, Wang JC (2017) A clinical practice guideline for the management of patients with degenerative cervical myelopathy: recommendations for patients with mild, moderate, and severe disease and nonmyelopathic patients with evidence of cord compression. Global Spine J 7:70S–83S. https://doi.org/10.1177/2192568217701914
Grodzinski B, Durham R, Mowforth O, Stubbs D, Kotter M, Davies BM (2020) The effect of ageing on presentation, management and outcomes in degenerative cervical myelopathy: a systematic review. Age Ageing. https://doi.org/10.1093/ageing/afaa236
Khan DZ, Davies BM, Kotter MRN (2020) Spinal research — a field in need of standardization. J Rheumatol 47:633–634. https://doi.org/10.3899/jrheum.191225
Mowforth OD, Davies BM, Goh S, O’Neill CP, Kotter MRN (2019) Research inefficiency in degenerative cervical myelopathy: findings of a systematic review on research activity over the past 20 years. Global Spine J. https://doi.org/10.1177/2192568219847439
Oh T, Lafage R, Lafage V, Protopsaltis T, Challier V, Shaffrey C, Kim HJ, Arnold P, Chapman J, Schwab F, Massicotte E, Yoon T, Bess S, Fehlings M, Smith J, Ames C (2017) Comparing quality of life in cervical spondylotic myelopathy with other chronic debilitating diseases using the Short Form Survey 36-Health Survey. World Neurosurg 106:699–706. https://doi.org/10.1016/j.wneu.2016.12.124
Smith SS, Stewart ME, Davies BM, Kotter MRN The prevalence of asymptomatic and symptomatic spinal cord compression on magnetic resonance imaging: a systematic review and meta-analysis. Global Spine J 0:2192568220934496. https://doi.org/10.1177/2192568220934496
Tetreault L, Kopjar B, Cote P, Arnold P, Fehlings MG (2015) A clinical prediction rule for functional outcomes in patients undergoing surgery for degenerative cervical myelopathy analysis of an international prospective multicenter data set of 757 subjects. J Bone Joint Surg (Am Vol) 97:2038–2046
Tetreault L, Wilson J, Kotter M, Kopjar B, Cote P, Arnold PM, Fehlings MG (2016) Predicting the minimum clinically important difference in patients undergoing surgery for the treatment of degenerative cervical myelopathy. Spine J 16:S337–S338
BMD is supported by a NIHR Clinical Doctoral Research Fellowship.
This article does not contain any studies with human participants or animals performed by any of the authors.
N/A – no human participants.
Conflict of interest
Author BMD is supported by a NIHR Clinical Doctoral Research Fellowship.
All other authors certify that they have no affiliations with or involvement in any organisation or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership or other equity interests; and expert testimony or patent-licencing arrangements), or non-financial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials discussed in this manuscript.
This report is an independent research arising from a Clinical Doctoral Research Fellowship supported by the National Institute for Health Research. The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health Research or the Department of Health and Social Care.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
This article is part of the Topical Collection on Spine degenerative
About this article
Cite this article
Grodzinski, B., Bestwick, H., Bhatti, F. et al. Research activity amongst DCM research priorities. Acta Neurochir 163, 1561–1568 (2021). https://doi.org/10.1007/s00701-021-04767-6